OSP News

Manufacturer Recalls Pravastatin Sodium 40 mg Tablets

Posted: 08/28/2017

As of August 9, 2017, International Laboratories, the manufacturer for pravastatin sodium tablets, initiated a recall. This medication is used to treat high cholesterol and prevent cardiovascular disease.

Recalled: One lot of pravastatin sodium tablets USP 40 mg packaged in bottles of 30 tablets:

  • NDC: 54458-925-16
  • Lot number: 115698A

International Laboratories recalled this lot of pravastatin sodium tablets from pharmacies since the product was incorrectly labeled. The product is labeled as pravastatin sodium tablets USP 40 mg but contained bupropion hydrochloride XL 300 mg tablets, used to treat depression.

Click here to find out more about the recall from the FDA. 

We value your privacy. We use cookies and other technologies to keep the web site reliable and secure, tailor your experience, and measure web site performance, as described in our Privacy Policy.

x

OSP Technical Support